Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease
Conditions: Multiple Myeloma; Extramedullary Plasmacytoma Interventions: Drug: Daratumumab; Drug: Bortezomib; Drug: Cyclophosphamide; Drug: Dexamethasone Sponsors: European Myeloma Network; Janssen, LP Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2019 Category: Research Source Type: clinical trials
Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma
Conditions: Multiple Myeloma in Relapse; Plasmacytoma; Daratumumab Intervention: Drug: Drug Combinations Sponsor: Seoul National University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2019 Category: Research Source Type: clinical trials